Bajaj Healthcare Ltd Performance
Day's Low
Day's High
₹530.35Day's Price Range₹57852 Week's Low
52 Week's High
₹263.352-Week Price Range₹578
| Returns % | |
| 1 Month Return | + 52.19 % |
| 3 Month Return | + 50.2 % |
| 1 Year Return | + 52.41 % |
| Market Stats | |
| Previous Close | ₹584.80 |
| Open | ₹567.00 |
| Volume | 15.00L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,762.50Cr |
Bajaj Healthcare Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹1,762.50 Cr |
| P/B Ratio | 2.9 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | -12.23 |
Bajaj Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,762.50 Cr | 12.22% | 0.79 | NA | NA | |
| NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
| NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
| BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
| NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
About Bajaj Healthcare Ltd
Share Price: ₹533.90 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,762.50Cr as of today
Listing date: 25 Nov, 2021
Chairperson Name: Sanjankumar R Bajaj
| Organisation | Bajaj Healthcare Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Bajaj Healthcare Ltd
Bajaj Healthcare Secures New CDMO Contracts - 10 Dec, 2024
Bajaj Healthcare announced a definitive CDMO contract for 15 new APIs with UK/EU clients, building on a previous contract. The stock hit a 52-week high following this news.Bajaj Healthcare Gains TGA Approval for API Site - 09 Dec, 2024
Bajaj Healthcare's API manufacturing site in Vadodara received approval from Australia's TGA, allowing direct supplies to Australia and New Zealand, boosting its global presence.Bajaj Healthcare Gains TGA Approval, Shares Surge - 07 Dec, 2024
Bajaj Healthcare's API manufacturing site in Gujarat received approval from Australia's TGA, enhancing its global supplier status. The company reported a significant profit increase and a 14% rise in share price.Bajaj Healthcare Gains TGA Approval for API Supply - 06 Dec, 2024
Bajaj Healthcare's Vadodara plant received approval from Australia's TGA to supply active pharmaceutical ingredients, enhancing its global market position. Shares rose by 13.38%.Bajaj Healthcare Reports Strong Q3 Growth - 26 Nov, 2024
Bajaj Healthcare's standalone net sales for September 2024 reached Rs 133.09 crore, up 31.5% YoY. Net profit surged 373.46% to Rs 9.46 crore, with EBITDA rising 34.51%. EPS increased to Rs 3.36. Shares closed at Rs 397.80, reflecting a 34.14% return over six months.
Insights on Bajaj Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 0.00% to 1.31% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.01% to 1.07% in Sep 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 32.26% to 37.78% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, BAJAJHCARE stock has moved up by 28.1%
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 83.1%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 16.1%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 67.73% to 59.19% in Sep 2024 quarter
Bajaj Healthcare Ltd Financials
Bajaj Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 59.19% | ||
| Foreign Institutions | 1.07% | 18966.07 | |
| Mutual Funds | 1.31% | 262200.00 | |
| Retail Investors | 37.78% | 17.11 | |
| Others | 0.66% | 36327.78 |
Bajaj Healthcare Ltd Key Indicators
Bajaj Healthcare Ltd Earnings and Dividends
Bajaj Healthcare Ltd Earnings Results
Bajaj Healthcare Ltd’s net profit jumped 373.41% since last year same period to ₹9.46Cr in the Q2 2024-2025. On a quarterly growth basis, Bajaj Healthcare Ltd has generated 32.68% jump in its net profits since last 3-months.
Read More about Earnings ResultsBajaj Healthcare Ltd Dividends May,2024
In the quarter ending March 2024, Bajaj Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.37%.
Read More about Dividends
Bajaj Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Bajaj Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Bajaj Healthcare Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Bajaj Healthcare Ltd shares.
Bajaj Healthcare Ltd (BAJAJHCARE) share price today is ₹533.9
Bajaj Healthcare Ltd is listed on NSE
Bajaj Healthcare Ltd is listed on BSE
- Today’s highest price of Bajaj Healthcare Ltd is ₹578.
- Today’s lowest price of Bajaj Healthcare Ltd is ₹530.35.
Today’s traded volume of Bajaj Healthcare Ltd(BAJAJHCARE) is 15.00L.
Today’s market capitalisation of Bajaj Healthcare Ltd(BAJAJHCARE) is ₹1762.5Cr.
| Bajaj Healthcare Ltd(BAJAJHCARE | Price |
|---|---|
52 Week High | ₹578 |
52 Week Low | ₹263.3 |
Bajaj Healthcare Ltd(BAJAJHCARE) share price is ₹533.9. It is down -7.63% from its 52 Week High price of ₹578
Bajaj Healthcare Ltd(BAJAJHCARE) share price is ₹533.9. It is up 102.77% from its 52 Week Low price of ₹263.3
| Bajaj Healthcare Ltd(BAJAJHCARE | Returns |
|---|---|
1 Day Returns | -50.9% |
1 Month Returns | 52.19% |
3 Month Returns | 50.2% |
1 Year Returns | 52.41% |